1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Peritoneal Mesothelioma: new trials by email Literature Review of Peritoneal Mesothelioma trials Research Report on Peritoneal Mesothelioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) tremelimumab plus MEDI4736 - Pleural Mesothelioma, Peritoneal Mesothelioma | Phase 2 | Unknown | Italian Network for Tumor Biotherapy Foundation | 40 | 2015-10-01 | 2015-10-27 |
Adenoma (1) · Lung Diseases (1) · Lung Neoplasms (1) · Mesothelioma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Mesothelial (1) · Pleural Neoplasms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
durvalumab (1) · tremelimumab (1)
Italian Network for Tumor Biotherapy Foundation (1)
Italy (1)